Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 845

1.

Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation.

Beliakova-Bethell N, Mukim A, White CH, Deshmukh S, Abewe H, Richman DD, Spina CA.

J Biol Chem. 2019 Feb 11. pii: jbc.RA118.005185. doi: 10.1074/jbc.RA118.005185. [Epub ahead of print]

2.

Reply to Ambrosioni et al.

Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, Richman DD.

Clin Infect Dis. 2018 Dec 6. doi: 10.1093/cid/ciy1022. [Epub ahead of print] No abstract available.

PMID:
30520997
3.

Preoperative Cardiac Evaluation for Noncardiac Surgery.

Tateosian VS, Richman DC.

Anesthesiol Clin. 2018 Dec;36(4):509-521. doi: 10.1016/j.anclin.2018.07.003. Review.

PMID:
30390775
4.

Improved assays to measure and characterize the inducible HIV reservoir.

Massanella M, Yek C, Lada SM, Nakazawa M, Shefa N, Huang K, Richman DD.

EBioMedicine. 2018 Oct;36:113-121. doi: 10.1016/j.ebiom.2018.09.036. Epub 2018 Oct 11.

5.

Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR.

Lada SM, Huang K, VanBelzen DJ, Montaner LJ, O'Doherty U, Richman DD.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e01158-18. doi: 10.1128/JCM.01158-18. Print 2018 Dec.

6.

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement.

Lofano G, Gorman MJ, Yousif AS, Yu WH, Fox JM, Dugast AS, Ackerman ME, Suscovich TJ, Weiner J, Barouch D, Streeck H, Little S, Smith D, Richman D, Lauffenburger D, Walker BD, Diamond MS, Alter G.

Sci Immunol. 2018 Aug 17;3(26). pii: eaat7796. doi: 10.1126/sciimmunol.aat7796.

7.

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.

Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, Richman DD.

Clin Infect Dis. 2019 Jan 7;68(2):177-187. doi: 10.1093/cid/ciy463.

8.

Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.

Papasavvas E, Lada SM, Joseph J, Yin X, Liu Q, Azzoni L, Mounzer K, Kostman JR, Richman D, Montaner LJ.

AIDS. 2018 Aug 24;32(13):1763-1772. doi: 10.1097/QAD.0000000000001909.

PMID:
30045057
9.

Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement.

Kline AD, Moss JF, Selicorni A, Bisgaard AM, Deardorff MA, Gillett PM, Ishman SL, Kerr LM, Levin AV, Mulder PA, Ramos FJ, Wierzba J, Ajmone PF, Axtell D, Blagowidow N, Cereda A, Costantino A, Cormier-Daire V, FitzPatrick D, Grados M, Groves L, Guthrie W, Huisman S, Kaiser FJ, Koekkoek G, Levis M, Mariani M, McCleery JP, Menke LA, Metrena A, O'Connor J, Oliver C, Pie J, Piening S, Potter CJ, Quaglio AL, Redeker E, Richman D, Rigamonti C, Shi A, Tümer Z, Van Balkom IDC, Hennekam RC.

Nat Rev Genet. 2018 Oct;19(10):649-666. doi: 10.1038/s41576-018-0031-0. Review.

PMID:
29995837
10.

Assessing wandering risk among individuals with Alzheimer's disease and dementia: a pilot study.

Barnard-Brak L, Richman DM, Owen DC.

Psychogeriatrics. 2018 Sep;18(5):388-392. doi: 10.1111/psyg.12336. Epub 2018 Jul 10.

PMID:
29987882
11.

Natural History and Outcomes of Cytologically Benign Thyroid Nodules in Children.

Cherella CE, Feldman HA, Hollowell M, Richman DM, Cibas ES, Smith JR, Angell TE, Wang Z, Alexander EK, Wassner AJ.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3557-3565. doi: 10.1210/jc.2018-00895.

PMID:
29982665
12.

Transplantation of CCR5∆32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection.

Rothenberger M, Wagner JE, Haase A, Richman D, Grzywacz B, Strain M, Lada S, Estes J, Fletcher CV, Podany AT, Anderson J, Schmidt T, Wietgrefe S, Schacker T, Verneris MR.

Open Forum Infect Dis. 2018 May 22;5(5):ofy090. doi: 10.1093/ofid/ofy090. eCollection 2018 May.

13.

Thyroid Nodules in Pediatric Patients: Sonographic Characteristics and Likelihood of Cancer.

Richman DM, Benson CB, Doubilet PM, Peters HE, Huang SA, Asch E, Wassner AJ, Smith JR, Cherella CE, Frates MC.

Radiology. 2018 Aug;288(2):591-599. doi: 10.1148/radiol.2018171170. Epub 2018 May 1.

PMID:
29714678
14.

Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment.

White CH, Beliakova-Bethell N, Lada SM, Breen MS, Hurst TP, Spina CA, Richman DD, Frater J, Magiorkinis G, Woelk CH.

Front Immunol. 2018 Apr 12;9:603. doi: 10.3389/fimmu.2018.00603. eCollection 2018.

15.

Telehealth and in-person training outcomes for novice discrete trial training therapists.

Sump LA, Richman DM, Schaefer AM, Grubb LM, Brewer AT.

J Appl Behav Anal. 2018 Jul;51(3):466-481. doi: 10.1002/jaba.461. Epub 2018 Apr 23.

PMID:
29683185
16.

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ.

Sci Transl Med. 2018 Apr 18;10(437). pii: eaar6759. doi: 10.1126/scitranslmed.aar6759.

17.

Recommendations for Preoperative Management of Frailty from the Society for Perioperative Assessment and Quality Improvement (SPAQI).

Alvarez-Nebreda ML, Bentov N, Urman RD, Setia S, Huang JC, Pfeifer K, Bennett K, Ong TD, Richman D, Gollapudi D, Alec Rooke G, Javedan H.

J Clin Anesth. 2018 Jun;47:33-42. doi: 10.1016/j.jclinane.2018.02.011. Epub 2018 Mar 15.

PMID:
29550619
18.

Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.

Ruggiero A, Cozzi-Lepri A, Beloukas A, Richman D, Khoo S, Phillips A, Geretti AM; ERAS Study Group.

Open Forum Infect Dis. 2018 Feb 3;5(2):ofy032. doi: 10.1093/ofid/ofy032. eCollection 2018 Feb.

19.

Reply.

Sanders DB, Harati Y, Juel VC, Lou JS, Marburger T, Pascuzzi RM, Peltier AC, Richman DP, Smith AG.

Muscle Nerve. 2018 May;57(5):E130-E131. doi: 10.1002/mus.26089. Epub 2018 Mar 1. No abstract available.

PMID:
29406616
20.

3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.

Sanders DB, Juel VC, Harati Y, Smith AG, Peltier AC, Marburger T, Lou JS, Pascuzzi RM, Richman DP, Xie T, Demmel V, Jacobus LR, Aleš KL, Jacobus DP; Dapper Study Team.

Muscle Nerve. 2018 Apr;57(4):561-568. doi: 10.1002/mus.26052. Epub 2018 Feb 2.

21.

Development of an in-vivo metric to aid visual inspection of single-case design data: Do we need to run more sessions?

Barnard-Brak L, Richman DM, Little TD, Yang Z.

Behav Res Ther. 2018 Mar;102:8-15. doi: 10.1016/j.brat.2017.12.003. Epub 2017 Dec 16.

PMID:
29277023
22.

Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors.

Sadanand S, Das J, Chung AW, Schoen MK, Lane S, Suscovich TJ, Streeck H, Smith DM, Little SJ, Lauffenburger DA, Richman DD, Alter G.

AIDS. 2018 Feb 20;32(4):443-450. doi: 10.1097/QAD.0000000000001716.

PMID:
29239894
23.

Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.

Cummins NW, Rizza S, Litzow MR, Hua S, Lee GQ, Einkauf K, Chun TW, Rhame F, Baker JV, Busch MP, Chomont N, Dean PG, Fromentin R, Haase AT, Hampton D, Keating SM, Lada SM, Lee TH, Natesampillai S, Richman DD, Schacker TW, Wietgrefe S, Yu XG, Yao JD, Zeuli J, Lichterfeld M, Badley AD.

PLoS Med. 2017 Nov 28;14(11):e1002461. doi: 10.1371/journal.pmed.1002461. eCollection 2017 Nov.

24.

Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.

Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, Tempelman HA, Venter WDF, Wensing AMJ.

Lancet Infect Dis. 2018 Feb;18(2):188-197. doi: 10.1016/S1473-3099(17)30681-3. Epub 2017 Nov 17. Erratum in: Lancet Infect Dis. 2017 Nov 24;:.

PMID:
29158101
25.

Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.

Chaillon A, Gianella S, Lada SM, Perez-Santiago J, Jordan P, Ignacio C, Karris M, Richman DD, Mehta SR, Little SJ, Wertheim JO, Smith DM.

J Virol. 2018 Jan 17;92(3). pii: e01589-17. doi: 10.1128/JVI.01589-17. Print 2018 Feb 1.

26.

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG.

PLoS Med. 2017 Nov 7;14(11):e1002417. doi: 10.1371/journal.pmed.1002417. eCollection 2017 Nov.

27.

Mark Wainberg.

Richman DD, Gallo RC.

Curr Opin HIV AIDS. 2017 Sep;12(5):423-424. doi: 10.1097/COH.0000000000000394. No abstract available.

PMID:
28771448
28.

Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.

Wagner GA, Landais E, Caballero G, Phung P, Kosakovsky Pond SL, Poignard P, Richman DD, Little SJ, Smith DM.

J Virol. 2017 Aug 10;91(17). pii: e00475-17. doi: 10.1128/JVI.00475-17. Print 2017 Sep 1.

29.

Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types.

Yek C, Massanella M, Peling T, Lednovich K, Nair SV, Worlock A, Vargas M, Gianella S, Ellis RJ, Strain MC, Busch MP, Nugent CT, Richman DD.

J Clin Microbiol. 2017 Aug;55(8):2544-2553. doi: 10.1128/JCM.00425-17. Epub 2017 Jun 7.

30.

Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART.

Beliakova-Bethell N, Hezareh M, Wong JK, Strain MC, Lewinski MK, Richman DD, Spina CA.

Virology. 2017 Aug;508:127-133. doi: 10.1016/j.virol.2017.05.008.

31.

Leiomyoma Infarction after Uterine Artery Embolization: Influence of Embolic Agent and Leiomyoma Size and Location on Outcome.

Lacayo EA, Richman DL, Acord MR, Wolfman DJ, Caridi TM, Desale SY, Spies JB.

J Vasc Interv Radiol. 2017 Jul;28(7):1003-1010. doi: 10.1016/j.jvir.2017.03.015. Epub 2017 May 4.

PMID:
28479027
32.

Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1.

Choi JY, Pond SLK, Anderson CM, Richman DD, Smith DM.

J Infect Dis. 2017 May 15;215(10):1506-1513. doi: 10.1093/infdis/jix184.

33.

Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.

Bissig D, Manjunath R, Traylor BR, Richman DP, Ng KL.

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):e102-e104. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.037. Epub 2017 Apr 14.

PMID:
28416406
34.

HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.

Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD, Garcia JV.

Nat Med. 2017 May;23(5):638-643. doi: 10.1038/nm.4319. Epub 2017 Apr 17.

35.

HIV: Finding latent needles in a haystack.

Richman DD.

Nature. 2017 Mar 23;543(7646):499-500. doi: 10.1038/nature21899. Epub 2017 Mar 15. No abstract available.

PMID:
28297707
36.

Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.

Vesa J, Chaillon A, Wagner GA, Anderson CM, Richman DD, Smith DM, Little SJ.

AIDS. 2017 May 15;31(8):1149-1158. doi: 10.1097/QAD.0000000000001445.

37.

Enriching Peptide Libraries for Binding Affinity and Specificity Through Computationally Directed Library Design.

Foight GW, Chen TS, Richman D, Keating AE.

Methods Mol Biol. 2017;1561:213-232. doi: 10.1007/978-1-4939-6798-8_13.

38.

A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.

Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA.

Top Antivir Med. 2017 Dec/Jan;24(4):142-151.

39.

2017 Update of the Drug Resistance Mutations in HIV-1.

Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD.

Top Antivir Med. 2017 Dec/Jan;24(4):132-133.

40.

"Watch out!": Effects of instructed threat and avoidance on human free-operant approach-avoidance behavior.

Schlund MW, Treacher K, Preston O, Magee SK, Richman DM, Brewer AT, Cameron G, Dymond S.

J Exp Anal Behav. 2017 Jan;107(1):101-122. doi: 10.1002/jeab.238.

PMID:
28101925
41.

Facial emotion recognition among typically developing young children: A psychometric validation of a subset of NimStim stimuli.

Barnard-Brak L, Abby L, Richman DM, Chesnut S.

Psychiatry Res. 2017 Mar;249:109-114. doi: 10.1016/j.psychres.2016.12.049. Epub 2016 Dec 30.

PMID:
28092789
42.

Social Communication Questionnaire scoring procedures for autism spectrum disorder and the prevalence of potential social communication disorder in ASD.

Barnard-Brak L, Richman DM, Chesnut SR, Little TD.

Sch Psychol Q. 2016 Dec;31(4):522-533. doi: 10.1037/spq0000144.

PMID:
27929321
43.

Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.

White CH, Moesker B, Beliakova-Bethell N, Martins LJ, Spina CA, Margolis DM, Richman DD, Planelles V, Bosque A, Woelk CH.

PLoS Pathog. 2016 Nov 29;12(11):e1006026. doi: 10.1371/journal.ppat.1006026. eCollection 2016 Nov.

44.

A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics.

Karris MY, Umlauf A, Vaida F, Richman D, Little S, Smith D.

Medicine (Baltimore). 2016 Nov;95(44):e5315.

45.

Attentional Networks in Adolescents with High-functioning Autism: An fMRI Investigation.

Hames EC, Rajmohan R, Fang D, Anderson R, Baker M, Richman DM, O'Boyle M.

Open Neuroimag J. 2016 Sep 30;10:102-110. eCollection 2016.

46.

Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort study.

Dimachkie MM, Abuzinadah AR, Barohn RJ, Oskarsson B, Rocke DM, Dengel K, Richman DP.

Neurology. 2016 Nov 8;87(19):2067-2068. No abstract available.

PMID:
27821567
47.

Descriptive analysis and comparison of strategic incremental rehearsal to "Business as Usual" sight-word instruction for an adult nonreader with intellectual disability.

Richman DM, Grubb L, Thompson S.

Dev Neurorehabil. 2018 Jan;21(1):23-31. doi: 10.1080/17518423.2016.1238412. Epub 2016 Oct 28.

PMID:
27792403
48.

HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.

Wagner GA, Chaillon A, Liu S, Franklin DR Jr, Caballero G, Kosakovsky Pond SL, Vaida F, Heaton RK, Letendre SL, Grant I, Richman DD, Smith DM.

AIDS. 2016 Nov 13;30(17):2591-2597.

49.

Lipoprotein-like receptor 4 antibodies in myasthenia gravis: pathogenic or protective.

Richman DP.

Eur J Neurol. 2016 Nov;23(11):1593-1594. doi: 10.1111/ene.13169. No abstract available.

PMID:
27753233

Supplemental Content

Loading ...
Support Center